Pancreatic cancer remains one of the deadliest cancers for which there is no current effective treatment.

Only one in ten people survive longer than five years, according to the American Cancer Society, and its incidence is on the rise. It is predicted to become the secondleading cause of cancerrelated deaths in the U.S. by 2030.

Join Cosimo Commisso, Ph.D., Director of the Cell and Molecular Biology of Cancer Program at Sanford Burnham Prebys, and learn about promising research breakthroughs toward effective treatments for pancreatic cancer:

• Learn about the Commisso lab’s original research on the way nutrient metabolism in pancreatic tumors supports tumor growth and spread. Drugs that target cancer metabolism may help starve tumors to death

• Understand how disrupting the pH balance of pancreatic cells can promote cancer cell death—a novel research approach to treating pancreatic cancer

• Hear about two novel cancer drug discovery projects that hold promise to help stop pancreatic cancer in its tracks

SPEAKERS
Cosimo Commisso, Ph.D.
Director and Associate Professor
Cell and Molecular Biology of Cancer Program
NCIDesignated Cancer Center
Sanford Burnham Prebys

Hervé Tiriac Ph.D.
Assistant Research Scientist
UC San Diego Health
Moores Cancer Center

Yijuan Zhang, Ph.D.
Postdoctoral Associate, Commisso Laboratory
NCIdesignated Cancer Center
Sanford Burnham Prebys